Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,191
archived clinical trials in
Constipation

Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Schaumburg, IL
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Schaumburg, IL
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Evansville, IN
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Evansville, IN
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Lafayette, IN
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Lafayette, IN
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Valparasio, IN
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Valparasio, IN
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Augusta, KA
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Augusta, KA
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Newton, KA
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Newton, KA
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Wichita, KA
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Wichita, KA
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Hartford, KY
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Hartford, KY
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Eunice, LA
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Eunice, LA
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Lake Charles, LA
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Lake Charles, LA
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Mandeville, LA
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Mandeville, LA
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Brockton, MA
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Brockton, MA
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Fall River, MA
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Fall River, MA
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
New Bedford, MA
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
New Bedford, MA
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Rochester, MI
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Rochester, MI
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Saginaw, MI
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Saginaw, MI
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Traverse City, MI
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Traverse City, MI
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Biloxi, MS
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Biloxi, MS
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Fremont, NE
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Fremont, NE
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Omaha, NE
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Omaha, NE
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Henderson, NV
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Henderson, NV
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Las Vegas, NV
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Trenton, NJ
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Trenton, NJ
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Albuquerque, NM
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
New York, NY
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
New York, NY
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Greensboro, NC
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Greensboro, NC
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Wilmington, NC
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Wilmington, NC
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Winston-Salem, NC
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Akron, OH
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Akron, OH
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Canton, OH
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Canton, OH
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Columbus, OH
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Columbus, OH
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Groveport, OH
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Groveport, OH
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Kettering, OH
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Kettering, OH
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Lebanon, OH
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Lebanon, OH
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Marion, OH
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Marion, OH
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Munroe Falls, OH
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Munroe Falls, OH
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Oklahoma City, OK
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Tulsa, OK
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Tulsa, OK
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Portland, OR
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Portland, OR
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Huntingdon Valley, PA
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Huntingdon Valley, PA
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Jenkintown, PA
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Jenkintown, PA
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Lansdale, PA
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Lansdale, PA
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Charleston, SC
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Charleston, SC
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Greer, SC
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Greer, SC
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Myrtle Beach, SC
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Myrtle Beach, SC
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Summerville, SC
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Summerville, SC
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Bristol, TN
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Bristol, TN
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Milan, TN
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Milan, TN
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Nashville, TN
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Nashville, TN
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Austin, TX
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Austin, TX
Click here to add this to my saved trials